跳至主要内容
临床试验/JPRN-UMIN000007101
JPRN-UMIN000007101已完成4 期

Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin 2 Type 1 Receptor Antagonist Based Therapy - Southern Heart Conference Clinical research

Southern Heart Conference0 个研究点目标入组 200 人开始时间: 2012年1月19日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patients with secondary hypertension 2) Patients with cardiac insufficiency (more than NYHA grade II) 3) Patients under treatment with thiazide diuretic 4) Pregnant patients including one trying to conceive pregnancy during the planned study period 5) Patients with severe liver dysfunction 6) Patients with renal failure (serum creatinine ≥2.0 mg/dL) 7) Patients with a history of hypersensitivity to ingredients of losartan and hydrochlorothiazide 8) Patients with a history of hypersensitivity to thiazide or thiazide-like diuretics 9) Patients who are considered not eligible for the study by the attending doctor due to medical reasons

研究者

发起方
Southern Heart Conference

相似试验